International Healthway Corporation Ltd. (Catalist:5WA) (‘IHC') agreed to acquire Healthway Medical Corporation Ltd. (Catalist:5NG) (‘Healthway Medical') from Fan Kow Hin, Chee Yin Meh, Aathar Ah Kong Andrew, Aathar Ah Tuk Henry, Jong Hee Sen and Wong Ong Ming Eric for approximately SGD 150 million in stock on June 19, 2015. Under the terms of the agreement, IHC will issue 2 new shares of its common stock as consideration for every 9 Healthway Medical shares held as at the books closure date. Upon completion of the transaction, HMC will become a subsidiary of International Healthway Corp Ltd whilst Healthway Medical Corp Lt will be delisted.

The transaction is subject to Healthway Medical and IHC shareholder's approval, sanction of by the Court, de-listing of Healthway stock from Catalist, third party approval, receipt of all applicable regulatory approvals and receipt of favorable opinions from financial advisors of IHC and Healthway Medical in support of the acquisition. Healthway Medical will be delisted from SGX-ST upon clearance of the sponsor. As on July 1, 2015, the Board of Directors of Healthway Medical Corporation Ltd. recommended the shareholders to take no action. On September 2, 2015 the transaction received confirmation from the Securities Industry Council. On September 3, 2015, a supplemental agreement amending certain scheme conditions, termination provisions and prescribed occurrences was entered. As on September 21, 2015, the deal terms were revised. As per the revised terms, one share of IHC will be issued in exchange of 4.3 shares of Healthway Medical Corporation. As of December 30, 2015, the long stop date for the satisfaction of the conditions has been extended to June 30, 2016. As of February 23, 2016, the meeting date of shareholders of Healthway Medical Corporation Limited has been extended to May, 2016.

SAC Capital Private Limited and CIMB Bank Berhad acted as financial advisor for Healthway Medical. Gwendolyn Gn of Shook Lin & Bok acted as a legal advisor to International Healthway Corporation Limited. Xandar Capital Pte Ltd acted as financial advisor for International Healthway Corporation Ltd.

International Healthway Corporation Ltd. (Catalist:5WA) (‘IHC') cancelled the acquisition of Healthway Medical Corporation Ltd. (Catalist:5NG) (‘Healthway Medical') from Fan Kow Hin, Chee Yin Meh, Aathar Ah Kong Andrew, Aathar Ah Tuk Henry, Jong Hee Sen and Wong Ong Ming Eric on August 8, 2016.